Literature DB >> 26328173

Re: The treatment of late-onset hypogonadism.

Önder Cangüven1.   

Abstract

Entities:  

Year:  2014        PMID： 26328173      PMCID： PMC4548390          DOI： 10.5152/tud.2014.9513569

Source DB:  PubMed          Journal:  Turk J Urol        ISSN： 2149-3235


× No keyword cloud information.
  7 in total

Review 1.  The treatment of late-onset hypogonadism.

Authors:  Oktay Üçer; Bilal Gümüş
Journal:  Turk J Urol       Date:  2014-03-24

2.  Do low testosterone levels contribute to the pathogenesis of asthma?

Authors:  Onder Canguven; Selami Albayrak
Journal:  Med Hypotheses       Date:  2011-02-01       Impact factor: 1.538

3.  Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.

Authors:  D Kapoor; E Goodwin; K S Channer; T H Jones
Journal:  Eur J Endocrinol       Date:  2006-06       Impact factor: 6.664

Review 4.  A new era of testosterone and prostate cancer: from physiology to clinical implications.

Authors:  Mohit Khera; David Crawford; Alvaro Morales; Andrea Salonia; Abraham Morgentaler
Journal:  Eur Urol       Date:  2013-08-16       Impact factor: 20.096

Review 5.  Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

Authors:  Shalender Bhasin; Glenn R Cunningham; Frances J Hayes; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2010-06       Impact factor: 5.958

Review 6.  Aging and declining testosterone: past, present, and hopes for the future.

Authors:  Barry R Zirkin; Joyce Lisa Tenover
Journal:  J Androl       Date:  2012-08-09

7.  Low serum testosterone and increased mortality in men with coronary heart disease.

Authors:  Chris J Malkin; Peter J Pugh; Paul D Morris; Sonia Asif; T Hugh Jones; Kevin S Channer
Journal:  Heart       Date:  2010-10-19       Impact factor: 5.994
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.